Contineum Pharma - CTNM Net earnings per share growth forecast for next year

Corporate company logo of Contineum Therapeutics, Inc. (CTNM)

Experienced leaders at Contineum Therapeutics, Inc. (CTNM) are focusing on the treatment of neuroinflammation, which is reflected in the shifting analyst expectations for EPS n+1 growth. Test transparency and the ability to build relationships with pharma behemoths support the share price, although reliance on single-product patents creates risks. Meanwhile, the -17.30 mark indicates a level of profit consolidation, signaling a buildup of momentum before a potential breakout.

Contineum Pharma (CTNM): Net earnings per share growth forecast for next year from 04/06/2024 to 11/17/2026

Summary analytical data breakdowns for Contineum Pharma (CTNM)

Fundamental company analysis:contineum-tx.com, CTNM
Finished products of Contineum Therapeutics Inc

Contineum Therapeutics, Inc. (CTNM) specializes in the development of innovative neurological drugs while maintaining strict control over laboratory waste. By analyzing the expected earnings per share (EPS) growth rate, investors can view a consolidated forecast from leading analysts regarding future profitability. This metric measures the percentage change in EPS, stripping the trend of market noise and emotional volatility. Positive momentum in this indicator signals an increase in the business's fundamental value.

Analysis of competing companies

Net earnings per share growth forecast for next year Jazz Pharmaceuticals|CYTK: Expected earnings per share trend next year|Net earnings per share growth forecast for next year PTC Bio (PTCT)|SRRK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Expected net earnings per share growth next year|EWTX - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rapport Therapeutics, Inc.|ALMS: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Kempharm ZVRA|Expected earnings per share growth for next year LRMR|Expected net earnings per share growth next year Capricor Therapeutics CAPR|Earnings growth forecast for next year TRDA|Expected earnings per share growth for next year Channel Therapeutics PTHS|Earnings growth forecast for next year MNOV (MediciNova)|Expected earnings per share trend next year SER|BTAI - Net earnings per share growth forecast for next year|promisneurosciences.com (PMN) - Expected earnings per share growth for next year|Apimeds (APUS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AEON|Net earnings per share growth forecast for next year NLS Pharma|Expected net earnings per share growth next year bionomics.com.au BNOX|Earnings growth forecast for next year HUGE|RETA (Reata Pharma) - Expected earnings per share trend next year